FDA/PhRMA May Create Database Of Hepatotoxins
Executive Summary
A pharmaceutical consortium could create a hepatotoxin database within the next 12 to 18 months, members of the FDA/PhRMA Hepatotoxicity Steering Committee suggested during a Nov. 8 meeting
You may also be interested in...
Drug Risk Assessment Needs IoM Report To Synthesize Research – CERTs
The Institute of Medicine should study the current state of pharmaceutical risk assessment and recommend methodological and research improvements, participants in a Centers for Education & Research on Therapeutics risk assessment workshop suggested
Drug Risk Assessment Needs IoM Report To Synthesize Research – CERTs
The Institute of Medicine should study the current state of pharmaceutical risk assessment and recommend methodological and research improvements, participants in a Centers for Education & Research on Therapeutics risk assessment workshop suggested
PhRMA/FDA Hepatox Group Wants Research On Liver Monitoring
Actelion's pulmonary hypertension agent Tracleer may provide an opportunity for FDA and industry to test new approaches for management of liver toxicity